NCT04966169

Brief Summary

The purpose of this 12-month prospective cohort study is to evaluate post-operatory pain, patient satisfaction, and treatment outcomes (i.e., healing) when the newly-developed, 510k FDA-approved multisonic energy GentleWAve System (Sonendo, Inc., Laguna Hills, CA) is used in complex root canal procedures.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 19, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

August 27, 2021

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

August 24, 2025

Status Verified

August 1, 2025

Enrollment Period

3.8 years

First QC Date

July 7, 2021

Last Update Submit

August 18, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Change from baseline of Cone Beam Computed Tomography Periapical Index (CBCTPAI) across 1 year

    This will be assessed by the evaluator measuring the estimated tooth on the CBCT and assigning an index score on the CBCT. A score of 0 denotes an intact periapical bone structure. A score of 1 denotes a diameter of periapical radiolucency \>0.5-1mm. A score of 2 denotes a diameter of periapical radiolucency \>1-2mm. A score of 3 denotes a diameter of periapical radiolucency \>2-4mm. A score of 4 denotes a diameter of periapical radiolucency \>4-8mm. A score of 5 denotes a diameter of periapical radiolucency \>8mm. A score of 6 denotes (n) + E = expansion of periapical cortical bone. A score of 7 denotes (n) + D = destruction of periapical cortical bone.

    Baseline; 6-months; 12 months

  • Change from baseline of peripical index (PAI) across 1 year.

    This will be assessed by asking the evaluator to evaluate the PAI score at each X-ray. A value of 1 denotes normal periapical structures. A value of 2 denotes small changes in the bone structure. A value of 3 denotes changes in bone structure with some mineral loss. A value of 4 denotes apical periodontitis with well-defined radiolucent areas. A value of 5 denotes severe apical periodontitis with exacerbating features.

    Baseline; 6-months post-baseline; 12 months post-baseline

  • Change from baseline of modified wound healing scale (Mod-CWHS) across 1 year

    This will be assessed by the evaluator evaluating the research subject's healing status on a scale of 1-3. A value of 1 is "Uneventful wound healing with no gingival edema, erythema, suppuration, discomfort or barrier exposure. A value of 2 is "Uneventful wound healing with slight gingival edema, erythema, or discomfort but no suppuration. 3 is a value of poor wound healing with significant gingival edema, erythema, discomfort, loss of barrier or any suppuration.

    6 months post-baseline; 12 months post-baseline

  • Change from baseline of pain severity in 0-10 pain severity scale across 1 year

    This will be assessed by asking the research subject their current level of pain on a 0-10 scale, and the patient will circle one line.

    Baseline; 2 days post-baseline; 1 weeks post-baseline; 2 weeks post-baseline; 6 months post-baseline; 12-months post-baseline

  • Change from Day 2 of research subject's thoughts on treatment result across 1 year.

    This will be assessed by asking the research subject to assess their own treatment result on a scale of 0 to 10 and circling one line.

    2 days post-baseline; 1-week post-baseline; 2-weeks post-baseline; 6-months post-baseline; 12 months post-baseline

Study Arms (1)

Sonendo GentleWave

EXPERIMENTAL

Every participant will receive the same experimental treatment, which is root canal therapy using the Sonendo GentleWave System.

Device: GentleWave System

Interventions

The GentleWave hydrodynamic cavitation system is a 510k FDA-approved multisonic energy system that is used in complex root canal procedures.

Sonendo GentleWave

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18+ years
  • Speak and Read English
  • Able to attend follow-up visits at 6 months AND 1 year (post-baseline treatment)
  • A tooth with no response to cold and electric pulp testing.
  • Tooth is a 1st or 2nd mandibular molar
  • Tooth has no response to cold/electric pulp testing
  • Tooth has a diagnosis of pulp necrosis with asymptomatic apical periodontitis
  • st and 2nd mandibular molars.
  • Current (i.e., taken within the last week) radiograph available (or done at screening, as needed)
  • A limited-volume, cone-beam computed tomography (CBCT) taken at the first visit confirms apical periodontitis (radiolucency).

You may not qualify if:

  • Patient has advanced untreated periodontal disease/recent periodontal surgery
  • Patient has non-odontogenic facial pan (e.g., face pain of unknown cause)
  • Patient has a history of poor attendance at dental visits
  • Patient is pregnant
  • Patient reports taking corticosteroids
  • Patient is supervised by the Principal Investigator or a member of the research team
  • Patient is subordinate to the Principal Investigator or a member of the research team
  • Patient is a student/trainee under the direction of the Principal Investigator or a member of the research team
  • Tooth had previous intervention (e.g., pulp debridement: removal of the pulp/nerve of the tooth)
  • Tooth has incomplete root formation (e.g., immature with apical periodontitis)
  • Tooth has defective restorations or carious lesions (i.e., cavities) that could lead to microleakage
  • Tooth has internal or external resorption
  • Tooth has a mobility score of 3
  • Tooth has a fracture/visibly cracked
  • Tooth has vital (i.e., functioning) pulp
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Iowa College of Dentistry and Dental Clinics

Iowa City, Iowa, 52242, United States

Location

Related Publications (4)

  • Grigsby D Jr, Ordinola-Zapata R, McClanahan SB, Fok A. Postoperative Pain after Treatment Using the GentleWave System: A Randomized Controlled Trial. J Endod. 2020 Aug;46(8):1017-1022. doi: 10.1016/j.joen.2020.04.004. Epub 2020 Jun 14.

    PMID: 32553417BACKGROUND
  • Sigurdsson A, Le KT, Woo SM, Rassoulian SA, McLachlan K, Abbassi F, Garland RW. Six-month healing success rates after endodontic treatment using the novel GentleWave System: The pure prospective multi-center clinical study. J Clin Exp Dent. 2016 Jul 1;8(3):e290-8. doi: 10.4317/jced.52779. eCollection 2016 Jul.

    PMID: 27398180BACKGROUND
  • Sigurdsson A, Garland RW, Le KT, Woo SM. 12-month Healing Rates after Endodontic Therapy Using the Novel GentleWave System: A Prospective Multicenter Clinical Study. J Endod. 2016 Jul;42(7):1040-8. doi: 10.1016/j.joen.2016.04.017.

    PMID: 27325455BACKGROUND
  • Wohlgemuth P, Cuocolo D, Vandrangi P, Sigurdsson A. Effectiveness of the GentleWave System in Removing Separated Instruments. J Endod. 2015 Nov;41(11):1895-8. doi: 10.1016/j.joen.2015.08.015. Epub 2015 Sep 26.

    PMID: 26409807BACKGROUND

MeSH Terms

Conditions

Periapical Periodontitis

Condition Hierarchy (Ancestors)

Periapical DiseasesJaw DiseasesStomatognathic DiseasesPeriodontal DiseasesMouth DiseasesPeriodontitis

Study Officials

  • Fabricio Teixeira, DDS,MS,PhD

    University of Iowa College of Dentistry

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2021

First Posted

July 19, 2021

Study Start

August 27, 2021

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

August 24, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations